Bicara Therapeutics (BCAX) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.68
-0.56
-0.45
-0.33

Details

Expected EPS
-0.541111
Actual EPS
-0.67
Surprise EPS
-0.13
Surprise Percent
+23.82%

Description

Bicara Therapeutics (BCAX) has reported earnings of -0.67 per share for Q4 2025.

0 Comments

Share your thoughts